prostate cancer precision medicine

This data describes our research into precision medicine for prostate cancer. This study employs Mendelian Randomization (MR) to investigate genetic variants as potential therapeutic targets by analyzing their relationship with prostate cancer risk.本数据集阐述了我们针对前列腺癌的精准医学研究工作。本研究采用孟德尔随机化（Mendelian Randomization，MR）方法，通过分析遗传变异与前列腺癌患病风险的关联，探究遗传变异作为潜在治疗靶点的可行性。